Interplay between Hepatitis C Virus and Redox Cell Signaling

Hepatitis C virus (HCV) infects approximately 3% of the world’s population. Currently licensed treatment of HCV chronic infection with pegylated-interferon-α and ribavirin, is not fully effective against all HCV genotypes and is associated to severe side effects. Thus, development of novel therapeut...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ruggieri, Anna, Anticoli, Simona, Nencioni, Lucia, Sgarbanti, Rossella, Garaci, Enrico, Palamara, Anna Teresa
Natura: Artigo
Lingua:Inglês
Pubblicazione: Molecular Diversity Preservation International (MDPI) 2013
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3634496/
https://ncbi.nlm.nih.gov/pubmed/23443167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms14034705
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi